Rhea N Coler Selected Research

Rhea N Coler Research Topics

Disease

29	Tuberculosis (Tuberculoses) 06/2023 - 04/2003
20	Infections 05/2023 - 06/2002
14	Leishmaniasis 11/2017 - 01/2002
10	Visceral Leishmaniasis (Kala Azar) 11/2017 - 02/2007
7	Human Influenza (Influenza) 01/2020 - 10/2010
6	COVID-19 07/2023 - 07/2021
4	Pulmonary Tuberculosis 01/2019 - 08/2011
4	Communicable Diseases (Infectious Diseases) 10/2018 - 04/2013
3	Neoplasms (Cancer) 09/2020 - 10/2015
3	Malaria 01/2017 - 12/2013
3	Cutaneous Leishmaniasis 09/2010 - 05/2009
2	Lung Diseases (Lung Disease) 07/2022 - 01/2022
2	Leprosy (Hansen's Disease) 11/2020 - 09/2014
2	Parasitic Diseases (Parasitic Disease) 05/2005 - 09/2002
1	Chronic Disease (Chronic Diseases) 12/2022
1	Breakthrough Infections 01/2022
1	Zika Virus Infection 09/2020
1	Pneumonia (Pneumonitis) 05/2018
1	Latent Infection 01/2017
1	Schistosomiasis (Bilharziasis) 01/2016
1	West Nile Fever 01/2016
1	Bovine Tuberculosis 10/2013
1	Poliomyelitis (Polio) 01/2011
1	Hypersensitivity (Allergy) 12/2009
1	Asymptomatic Infections 12/2009

Drug/Important Bio-Agent (IBA)

55	VaccinesIBA 07/2023 - 08/2002
22	AntigensIBA 12/2022 - 06/2002
15	Proteins (Proteins, Gene)FDA Link 07/2023 - 06/2002
8	Subunit VaccinesIBA 01/2017 - 12/2008
6	AntibodiesIBA 01/2023 - 01/2016
6	EmulsionsIBA 01/2020 - 05/2009
5	CytokinesIBA 05/2018 - 10/2010
4	PolyproteinsIBA 10/2010 - 08/2002
3	Neutralizing AntibodiesIBA 07/2023 - 01/2020
3	Tuberculosis VaccinesIBA 05/2023 - 04/2013
3	RNA (Ribonucleic Acid)IBA 05/2023 - 10/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 04/2013
3	Recombinant ProteinsIBA 01/2022 - 06/2002
2	BNT162 VaccineIBA 07/2023 - 01/2022
2	2019-nCoV Vaccine mRNA-1273IBA 07/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 07/2023 - 01/2023
2	Ad26COVS1IBA 07/2023 - 01/2022
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 07/2013
2	EpitopesIBA 01/2019 - 09/2002
2	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 12/2017
2	glucopyranosyl lipid-AIBA 01/2017 - 01/2016
2	BCG Vaccine FDA Link 11/2015 - 10/2011
2	Vaccine AdjuvantsIBA 03/2014 - 06/2002
2	Sulfhydryl Compounds (Thiols)IBA 09/2007 - 08/2002
2	Leishmania major stress-inducible protein 1IBA 09/2007 - 08/2002
2	theasinensin AIBA 09/2007 - 09/2002
2	AntioxidantsIBA 09/2007 - 08/2002
2	Peptide Initiation Factors (Initiation Factor)IBA 09/2007 - 08/2002
1	NVX-CoV2373 adjuvated lipid nanoparticleIBA 07/2023
1	Saline SolutionIBA 06/2023
1	COVID-19 VaccinesIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Monoclonal AntibodiesIBA 09/2020
1	SqualeneIBA 01/2020
1	LipidsIBA 01/2020
1	NucleoproteinsIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	AerosolsIBA 01/2019
1	Combined VaccinesIBA 11/2017
1	Leishmaniasis VaccinesIBA 11/2017
1	Cysteine Proteases (Cysteine Protease)IBA 01/2017
1	Recombinant Fusion ProteinsIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015
1	InterferonsIBA 08/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2015
1	Interferon-gamma (Interferon, gamma)IBA 09/2014
1	Tuberculin (PPD)IBA 09/2014
1	Protein Subunit VaccinesIBA 12/2013
1	Viral ProteinsIBA 07/2013
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2013
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2013
1	Mycobacterium tuberculosis antigensIBA 08/2011
1	Poliovirus VaccinesIBA 01/2011
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 10/2010
1	Interleukin-2 (IL2)IBA 10/2010
1	Meglumine AntimoniateIBA 09/2010
1	monophosphoryl lipid AIBA 05/2009
1	SterolsIBA 10/2007
1	AntimonyIBA 10/2006
1	OligodeoxyribonucleotidesIBA 06/2002
1	CPG-oligonucleotideIBA 06/2002
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2002

Therapy/Procedure

6	Therapeutics 05/2023 - 10/2006
3	Drug Therapy (Chemotherapy) 01/2023 - 08/2011
2	Injections 10/2010 - 09/2010
1	Intramuscular Injections 06/2023
1	Duration of Therapy 04/2013
1	Immunotherapy 10/2006